Structure–activity relationship of novel low-generation dendrimers for gene delivery-Reference-Cited by-同舟云学术

Structure–activity relationship of novel low-generation dendrimers for gene delivery

Published:2018 Issue:42 Volume:16 Page:7833-7842
ISSN:1477-0520
Container-title:Organic & Biomolecular Chemistry
language:en
Short-container-title:Org. Biomol. Chem.

Author:

Gao Yong-Guang¹²³⁴⁵,Lin Xiao¹²³⁴⁵,Dang Kai¹²³⁴⁵,Jiang Shan-Feng¹²³⁴⁵,Tian Ye¹²³⁴⁵,Liu Fen-Li¹²³⁴⁵,Li Di-Jie¹²³⁴⁵,Li Yu¹²³⁴⁵,Miao Zhi-Ping¹²³⁴⁵,Qian Ai-Rong¹²³⁴⁵

Affiliation:

1. Lab for Bone Metabolism

2. Key Lab for Space Biosciences and Biotechnology

3. School of Life Sciences

4. Northwestern Polytechnical University

5. Xi'an, Shanxi 710072

Abstract

Structure–activity relationship (SAR) studies are very critical to design ideal gene vectors for gene delivery.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Physical and Theoretical Chemistry,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2018/OB/C8OB01767K

Reference63 articles.

1. Gene therapy 'cure' for blindness wanes

2. Gene Therapy 2017: Progress and Future Directions

3. Gene-editing therapy for neurological disease

4. Germline gene therapy: We're ready

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Core-size and geometry versus toxicity in small amino terminated PAMAM dendrimers;RSC Advances;2024

2. Overcoming barriers: a review on innovations in drug delivery to the middle and inner ear;Frontiers in Pharmacology;2023-10-19

3. Understanding Physico-chemical Interactions of Dendrimers with Guest Molecules for Efficient Drug and Gene Delivery;Current Pathobiology Reports;2021-03-06

4. Polyvinylidene difluoride film with embedded poly(amidoamine) modified graphene oxide for extraction of chlorpyrifos and diazinon;Microchimica Acta;2021-01-11

5. Advances in targeted dendrimers for cancer therapy and challenges for clinical translation;Dendrimer-Based Nanotherapeutics;2021